Show simple item record

dc.contributor.authorWilliams, CA
dc.contributor.authorSaynor, ZL
dc.contributor.authorBarker, AR
dc.contributor.authorOades, PJ
dc.contributor.authorTomlinson, OW
dc.date.accessioned2017-11-03T14:48:40Z
dc.date.issued2017-10-01
dc.identifier.citationVol. 123 (4), article 1017en_GB
dc.identifier.doi10.1152/japplphysiol.00538.2017
dc.identifier.urihttp://hdl.handle.net/10871/30148
dc.language.isoenen_GB
dc.publisherAmerican Physiological Societyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/29074571en_GB
dc.rights.embargoreasonPublisher policyen_GB
dc.rightsCopyright © 2017 the American Physiological Societyen_GB
dc.titleMeasurement of V̇o2max in clinical groups is feasible and necessaryen_GB
dc.typeArticleen_GB
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from American Physiological Society via the DOI in this record.en_GB
dc.identifier.journalJournal of Applied Physiologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record